Proteomics International Laboratories Limited PIQ.AX Stock
Proteomics International Laboratories Limited Price Chart
Proteomics International Laboratories Limited PIQ.AX Financial and Trading Overview
Contents
- Proteomics International Laboratories Limited Price Chart
- Proteomics International Laboratories Limited PIQ.AX Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Proteomics International Laboratories Limited
- Q&A For Proteomics International Laboratories Limited Stock
Proteomics International Laboratories Limited stock price | 1.16 AUD |
Previous Close | 0.83 AUD |
Open | 0.83 AUD |
Bid | 0.84 AUD x 0 |
Ask | 0.85 AUD x 0 |
Day's Range | 0.82 - 0.84 AUD |
52 Week Range | 0.61 - 1.18 AUD |
Volume | 63.01K AUD |
Avg. Volume | 80.4K AUD |
Market Cap | 101.54M AUD |
Beta (5Y Monthly) | 0.603 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.05 AUD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.42 AUD |
PIQ.AX Valuation Measures
Enterprise Value | 95.52M AUD |
Trailing P/E | N/A |
Forward P/E | -27.666666 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 31.919806 |
Price/Book (mrq) | 12.028986 |
Enterprise Value/Revenue | 30.027 |
Enterprise Value/EBITDA | -16.367 |
Trading Information
Proteomics International Laboratories Limited Stock Price History
Beta (5Y Monthly) | 0.603 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 1.18 AUD |
52 Week Low | 0.61 AUD |
50-Day Moving Average | 0.91 AUD |
200-Day Moving Average | 0.89 AUD |
PIQ.AX Share Statistics
Avg. Volume (3 month) | 80.4K AUD |
Avg. Daily Volume (10-Days) | 71.5K AUD |
Shares Outstanding | 122.34M |
Float | 78.77M |
Short Ratio | N/A |
% Held by Insiders | 35.27% |
% Held by Institutions | 0.67% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | June 30, 2023 |
Most Recent Quarter (mrq) | June 30, 2023 |
Next Fiscal Year End | June 30, 2024 |
Profitability
Profit Margin | -194.16% |
Operating Margin (ttm) | -96.44% |
Gross Margin | 26.26% |
EBITDA Margin | -183.46% |
Management Effectiveness
Return on Assets (ttm) | -51.42% |
Return on Equity (ttm) | -106.41% |
Income Statement
Revenue (ttm) | 3.18M AUD |
Revenue Per Share (ttm) | 0.03 AUD |
Quarterly Revenue Growth (yoy) | -13.30% |
Gross Profit (ttm) | 835.59K AUD |
EBITDA | -5836071 AUD |
Net Income Avi to Common (ttm) | -6176573 AUD |
Diluted EPS (ttm) | -0.05 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 6.03M AUD |
Total Cash Per Share (mrq) | 0.05 AUD |
Total Debt (mrq) | 64.09K AUD |
Total Debt/Equity (mrq) | 0.77 AUD |
Current Ratio (mrq) | 7.551 |
Book Value Per Share (mrq) | 0.069 |
Cash Flow Statement
Operating Cash Flow (ttm) | -5692911 AUD |
Levered Free Cash Flow (ttm) | -5020831 AUD |
Profile of Proteomics International Laboratories Limited
Country | Australia |
State | WA |
City | Perth |
Address | QEII Medical Centre |
ZIP | 6009 |
Phone | 61 8 9389 1992 |
Website | https://www.proteomics.com.au |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Proteomics International Laboratories Limited operates as a medical technology company with a focus on the area of proteomics. It provides PromarkerD, a predictive test for diabetic kidney disease; and develops diagnostic tests for endometriosis and giardia. The company also offers analytical services, including specialist contract research. The company was founded in 2001 and is based in Perth, Australia.
Q&A For Proteomics International Laboratories Limited Stock
What is a current PIQ.AX stock price?
Proteomics International Laboratories Limited PIQ.AX stock price today per share is 1.16 AUD.
How to purchase Proteomics International Laboratories Limited stock?
You can buy PIQ.AX shares on the ASX exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Proteomics International Laboratories Limited?
The stock symbol or ticker of Proteomics International Laboratories Limited is PIQ.AX.
Which industry does the Proteomics International Laboratories Limited company belong to?
The Proteomics International Laboratories Limited industry is Biotechnology.
How many shares does Proteomics International Laboratories Limited have in circulation?
The max supply of Proteomics International Laboratories Limited shares is 130.89M.
What is Proteomics International Laboratories Limited Price to Earnings Ratio (PE Ratio)?
Proteomics International Laboratories Limited PE Ratio is now.
What was Proteomics International Laboratories Limited earnings per share over the trailing 12 months (TTM)?
Proteomics International Laboratories Limited EPS is -0.05 AUD over the trailing 12 months.
Which sector does the Proteomics International Laboratories Limited company belong to?
The Proteomics International Laboratories Limited sector is Healthcare.